DaveManuel.com · Institutional Ownership · Who Owns It
OCULAR THERAPEUTIX INC (OCUL)
Institutional ownership reported to the SEC as of Q2 2026, across 32 quarters.
265
Reporting holders
$2.1B
Reported value
94.4%
Of shares outstanding
1.0%
Calls
0.3%
Puts
-11
Holder change
Institutions report 207,288,450 shares against 219,615,868 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. A figure this high can overstate: where an adviser and a sub-adviser both report the same shares, both are counted.
Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| FMR LLC | $322.5M | 32,844,043 | 0.01% | 18q | +0.6%+$1.9M |
| Deep Track Capital, LP | $193.3M | 19,686,282 | 2.81% | 11q | HELD |
| BlackRock, Inc. | $190.3M | 19,376,555 | 0.00% | 8q | +20.1%+$31.9M |
| Avoro Capital Advisors LLC | $123.1M | 12,540,000 | 1.11% | 10q | +1.8%+$2.2M |
| Summer Road LLC | $119.9M | 12,208,296 | 74.46% | 31q | +2.8%+$3.2M |
| Venrock Adviser, LLC | $101.6M | 10,346,926 | 3.08% | 11q | HELD |
| VANGUARD CAPITAL MANAGEMENT LLC | $86.7M | 8,832,595 | 0.00% | 2q | +1.3%+$1.1M |
| PRICE T ROWE ASSOCIATES INC /MD/ | $74.9M | 7,623,533 | 0.01% | 23q | +29.3%+$17.0M |
| Logos Global Management LP | $52.0M | 5,300,000 | 2.24% | 11q | +37.7%+$14.2M |
| STATE STREET CORP | $51.4M | 5,233,282 | 0.00% | 31q | +11.1%+$5.2M |
| GEODE CAPITAL MANAGEMENT, LLC | $49.3M | 5,021,092 | 0.00% | 31q | +10.9%+$4.8M |
| Point72 Asset Management, L.P. | $32.3M | 3,292,193 | 0.04% | 9q | -40.5%-$22.0M |
| Balyasny Asset Management L.P. | $31.9M incl. $9.6M options CALL | 2,270,707 | 0.04% | 7q | -15.7%-$5.9M |
| DIMENSIONAL FUND ADVISORS LP | $27.3M | 2,783,367 | 0.00% | 2q | +328.4%+$21.0M |
| DELTEC ASSET MANAGEMENT LLC | $24.3M | 2,476,197 | 3.59% | 31q | +5.8%+$1.3M |
| Octagon Capital Advisors LP | $20.4M | 2,075,000 | 1.83% | 10q | -34.5%-$10.7M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.4M | 1,973,130 | 0.00% | 2q | +23.7%+$3.7M |
| NORTHERN TRUST CORP | $17.7M | 1,799,426 | 0.00% | 31q | +17.9%+$2.7M |
| GOLDMAN SACHS GROUP INC | $17.3M | 1,761,754 | 0.00% | 31q | +58.7%+$6.4M |
| Nuveen, LLC | $16.7M | 1,697,274 | 0.00% | 6q | +312.9%+$12.6M |
| Woodline Partners LP | $16.4M | 1,667,609 | 0.05% | 8q | HELD |
| TCG Crossover Management, LLC | $16.2M | 1,647,752 | 0.39% | 10q | HELD |
| UBS Group AG | $15.2M | 1,551,001 | 0.00% | 31q | +2.0%+$298.2K |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $15.2M | 1,550,000 | 0.02% | new | NEW |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15.1M | 1,533,438 | 0.00% | 31q | +4.9%+$709.6K |
| Defilade Capital Management, L.P. | $14.6M | 1,490,286 | 1.96% | 3q | HELD |
| Squarepoint Ops LLC | $13.9M | 1,415,913 | 0.02% | 4q | +44.4%+$4.3M |
| Invesco Ltd. | $13.2M | 1,344,391 | 0.00% | 26q | -12.5%-$1.9M |
| Boxer Capital Management, LLC | $12.8M | 1,300,000 | 0.96% | 2q | +271.4%+$9.3M |
| VANGUARD FIDUCIARY TRUST CO | $12.7M | 1,289,200 | 0.00% | 2q | +3.5%+$433.8K |
| TWO SIGMA INVESTMENTS, LP | $12.0M | 1,218,513 | 0.01% | 16q | -33.4%-$6.0M |
| Knoll Capital Management, LLC | $11.3M | 1,150,400 | 5.27% | 14q | +91.6%+$5.4M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.2M incl. $6.5M options CALL+PUT | 484,120 | 0.00% | 31q | +221.2%+$7.7M |
| HRT FINANCIAL LP | $10.6M | 1,077,090 | 0.02% | 4q | +51.9%+$3.6M |
| RAYMOND JAMES FINANCIAL INC | $9.5M | 963,316 | 0.00% | 7q | +12.1%+$1.0M |
| AQR CAPITAL MANAGEMENT LLC | $9.3M | 950,338 | 0.00% | 8q | +90.3%+$4.4M |
| MORGAN STANLEY | $9.0M | 911,831 | 0.00% | 35q | -28.8%-$3.6M |
| Candriam S.C.A. | $8.9M | 907,839 | 0.04% | 3q | -4.4%-$405.9K |
| Empire Life Investments Inc. | $8.6M | 871,692 | 0.48% | 4q | -1.4%-$123.8K |
| CITADEL ADVISORS LLC | $8.0M incl. $5.0M options CALL+PUT | 310,484 | 0.00% | 31q | -51.2%-$8.4M |
| Cetera Investment Advisers | $7.7M | 785,732 | 0.01% | 20q | +2.8%+$207.4K |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7.4M | 753,495 | 0.24% | 6q | +4.6%+$324.4K |
| TUDOR INVESTMENT CORP ET AL | $6.8M incl. $1.7M options CALL | 522,663 | 0.01% | 4q | -14.9%-$1.2M |
| Aptus Capital Advisors, LLC | $6.3M | 638,691 | 0.04% | 9q | +20.6%+$1.1M |
| Second Line Capital, LLC | $6.3M | 638,640 | 1.17% | 9q | +20.9%+$1.1M |
| Opaleye Management Inc. | $5.9M | 600,000 | 0.53% | 30q | HELD |
| ALGERT GLOBAL LLC | $5.8M | 592,309 | 0.07% | 3q | +9.9%+$524.1K |
| Bank of New York Mellon Corp | $5.4M | 553,236 | 0.00% | 31q | +16.2%+$758.6K |
| Man Group plc | $5.3M | 543,582 | 0.01% | 3q | +206.3%+$3.6M |
| Sio Capital Management, LLC | $5.3M | 539,493 | 0.88% | 2q | -44.3%-$4.2M |
| ACUTA CAPITAL PARTNERS, LLC | $5.2M | 532,481 | 3.64% | 11q | -10.1%-$585.5K |
| BANK OF AMERICA CORP /DE/ | $5.1M | 519,231 | 0.00% | 31q | +30.8%+$1.2M |
| JPMORGAN CHASE & CO | $4.9M | 482,293 | 0.00% | 31q | -7.4%-$386.5K |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $4.7M | 482,154 | 0.62% | 11q | +22.8%+$878.3K |
| Principia Wealth Advisory, LLC | $4.3M | 440,618 | 2.15% | 2q | +7.8%+$313.5K |
| BEACON INVESTMENT ADVISORS LLC | $4.3M | 435,131 | 1.34% | 3q | +1.0%+$41.8K |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4.2M | 423,011 | 0.00% | 5q | -4.2%-$184.3K |
| Trexquant Investment LP | $4.1M | 418,781 | 0.02% | new | NEW |
| HighVista Strategies LLC | $4.0M | 408,534 | 0.91% | 9q | -7.5%-$324.4K |
| E. Ohman J:or Asset Management AB | $3.8M | 385,000 | 0.09% | 2q | +28.3%+$834.7K |
| Rock Springs Capital Management LP | $3.8M | 383,716 | 0.18% | 4q | HELD |
| RENAISSANCE TECHNOLOGIES LLC | $3.7M | 378,754 | 0.01% | 3q | -67.0%-$7.6M |
| Propel Bio Management, LLC | $3.5M | 357,966 | 1.84% | 2q | -6.4%-$239.7K |
| Jump Financial, LLC | $3.4M | 350,937 | 0.03% | 4q | -12.7%-$499.8K |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.3M | 335,666 | 0.01% | 3q | -28.6%-$1.3M |
| BNP PARIBAS FINANCIAL MARKETS | $3.0M | 308,903 | 0.00% | 30q | +311.0%+$2.3M |
| Swiss National Bank | $3.0M | 305,800 | 0.00% | 9q | -2.4%-$73.7K |
| KVP Capital Advisors, LP | $2.9M | 300,000 | 2.16% | 2q | HELD |
| Verition Fund Management LLC | $2.9M | 299,199 | 0.01% | 6q | -43.3%-$2.2M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $2.8M | 287,158 | 0.00% | 9q | -7.0%-$213.6K |
| RHUMBLINE ADVISERS | $2.7M | 270,642 | 0.00% | 31q | +17.1%+$388.3K |
| BARCLAYS PLC | $2.5M | 250,690 | 0.00% | 31q | +68.3%+$998.8K |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.4M | 248,048 | 0.00% | 3q | +5.8%+$132.6K |
| Walleye Capital LLC | $2.3M incl. $341.7K options CALL+PUT | 201,782 | 0.01% | 4q | -72.8%-$6.2M |
| WELLS FARGO & COMPANY/MN | $2.3M | 231,073 | 0.00% | 31q | +104.9%+$1.2M |
| Advisory Services Network, LLC | $2.3M | 230,454 | 0.03% | 2q | +65.9%+$899.1K |
| TD Asset Management Inc | $2.3M | 229,800 | 0.00% | 2q | -3.4%-$80.5K |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.3M | 229,256 | 0.00% | 31q | +0.6%+$14.2K |
| Rhenman & Partners Asset Management AB | $2.2M | 225,000 | 0.21% | 4q | -26.2%-$785.6K |
| DEUTSCHE BANK AG\ | $2.2M | 224,145 | 0.00% | 34q | -64.5%-$4.0M |
| SIMPLEX TRADING, LLC | $2.2M incl. $832.7K options CALL+PUT | 136,256 | 0.00% | 11q | +2352.9%+$2.1M |
| ORBIMED ADVISORS LLC | $2.2M | 220,000 | 0.04% | new | NEW |
| SEI INVESTMENTS CO | $2.0M | 208,650 | 0.00% | 8q | -19.2%-$486.2K |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.0M | 207,784 | 0.00% | 31q | -2.8%-$58.2K |
| ALLIANCEBERNSTEIN L.P. | $1.9M | 227,020 | 0.00% | 31q | -94.5%-$33.1M |
| Russell Investments Group, Ltd. | $1.9M | 192,322 | 0.00% | 4q | +25.8%+$387.3K |
| CSM Advisors, LLC | $1.9M | 190,194 | 0.04% | new | NEW |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.9M | 188,368 | 0.00% | 3q | HELD |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.8M | 186,356 | 0.02% | 2q | +40.5%+$527.6K |
| Exome Asset Management LLC | $1.8M | 181,588 | 1.10% | new | NEW |
| GROUP ONE TRADING LLC | $1.7M incl. $1.5M options CALL+PUT | 13,823 | 0.00% | 16q | HELD |
| J. Goldman & Co LP | $1.7M incl. $663.8K options PUT | 101,760 | 0.04% | new | NEW |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1.7M | 169,064 | 0.00% | 3q | +1.9%+$30.2K |
| Steward Partners Investment Advisory, LLC | $1.6M | 165,142 | 0.01% | 29q | +85.0%+$745.1K |
| Wealthspire Advisors, LLC | $1.6M | 162,960 | 0.01% | new | NEW |
| Legato Capital Management LLC | $1.6M | 161,460 | 0.13% | 11q | +32.4%+$388.0K |
| WESBANCO BANK INC | $1.5M | 149,000 | 0.04% | 2q | +44.7%+$451.7K |
| CITIGROUP INC | $1.4M | 140,718 | 0.00% | 31q | +152.3%+$834.1K |
| MARSHALL WACE, LLP | $1.2M | 126,033 | 0.00% | 4q | -83.0%-$6.0M |
| D. E. Shaw & Co., Inc. | $1.2M | 124,457 | 0.00% | 7q | -43.0%-$923.3K |
Showing the largest 100 of 265 reported holders.
What the company announced
Form 8-K filings from the last 120 days, showing only the items worth a reader's attention. Earnings releases, exhibit attachments and general disclosures are filed constantly and are left out. Filed is when the SEC received it; event is the date the company says the thing happened.
| Filed | Event date | What | Source |
|---|---|---|---|
| 2026-10-16 | 2026-10-14 | Directors or officers departed or appointed | filing |
What the insiders did
Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.
Officers and directors
| Date | Insider | Role | Side | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Dugel Pravin | See Remarks | Sold | 21,649 | $233.2K |
| 2026-05-26 | Dugel Pravin | See Remarks | Sold | 21,156 | $173.5K |
| 2026-06-03 | Waheed Nadia | Chief Medical Officer | Sold | 14,828 | $122.6K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 47 | $32.7M | 4,255,969 | 3 | 17 | 12 | 0.0% |
| Q2 2026 | 265 | $2.1B | 207,288,450 | 30 | 105 | 81 | 1.4% |
| Q1 2026 | 276 | $1.8B | 207,188,137 | 71 | 101 | 59 | 2.4% |
| Q4 2025 | 254 | $2.4B | 191,646,245 | 52 | 102 | 58 | 2.9% |
| Q3 2025 | 221 | $2.2B | 188,459,296 | 51 | 68 | 58 | 1.5% |
| Q2 2025 | 189 | $1.5B | 157,451,674 | 23 | 70 | 45 | 0.9% |
| Q1 2025 | 198 | $1.0B | 137,703,422 | 33 | 55 | 53 | 0.7% |
| Q4 2024 | 181 | $1.2B | 133,836,935 | 24 | 59 | 36 | 0.7% |
| Q3 2024 | 167 | $1.2B | 140,044,394 | 35 | 36 | 47 | 0.4% |
| Q2 2024 | 149 | $992.1M | 144,269,291 | 35 | 56 | 26 | 0.5% |
| Q1 2024 | 148 | $1.2B | 126,979,690 | 47 | 59 | 21 | 1.5% |
| Q4 2023 | 118 | $335.6M | 74,735,531 | 26 | 37 | 27 | 0.7% |
| Q3 2023 | 115 | $128.3M | 40,429,642 | 8 | 42 | 28 | 1.1% |
| Q2 2023 | 137 | $231.2M | 43,458,441 | 28 | 39 | 38 | 3.0% |
| Q1 2023 | 127 | $220.4M | 40,614,723 | 27 | 37 | 33 | 2.7% |
| Q4 2022 | 114 | $112.8M | 39,609,376 | 11 | 34 | 44 | 1.3% |
| Q3 2022 | 125 | $764.5M | 160,725,059 | 23 | 42 | 32 | 0.5% |
| Q2 2022 | 119 | $4.7B | 1,174,997,833 | 15 | 36 | 31 | 0.0% |
| Q1 2022 | 127 | $783.2M | 155,937,063 | 15 | 37 | 38 | 0.2% |
| Q4 2021 | 137 | $1.1B | 160,957,477 | 23 | 44 | 41 | 0.6% |
| Q3 2021 | 138 | $2.1B | 210,570,562 | 16 | 44 | 44 | 1.3% |
| Q2 2021 | 146 | $4.6B | 326,783,680 | 28 | 57 | 34 | 0.8% |
| Q1 2021 | 147 | $2.3B | 142,287,872 | 25 | 51 | 41 | 0.8% |
| Q4 2020 | 147 | $1.6B | 77,212,140 | 49 | 44 | 33 | 1.3% |
| Q3 2020 | 104 | $528.1M | 68,877,934 | 15 | 36 | 31 | 0.7% |
| Q2 2020 | 105 | $19.0B | 2,284,525,709 | 24 | 52 | 9 | 0.0% |
| Q1 2020 | 92 | $11.3B | 2,282,467,938 | 28 | 23 | 23 | 0.0% |
| Q4 2019 | 77 | $8.9B | 2,243,918,827 | 11 | 19 | 19 | 0.0% |
| Q3 2019 | 74 | $6.8B | 2,241,546,499 | 11 | 27 | 13 | 0.0% |
| Q2 2019 | 69 | $9.9B | 2,241,547,006 | 14 | 23 | 14 | 0.0% |
| Q1 2019 | 69 | $8.9B | 2,240,868,936 | 6 | 25 | 19 | 0.0% |
| Q4 2018 | 68 | $8.9B | 2,240,444,687 | 1 | 1 | 1 | 0.0% |